Karsten Henco
26Patents
10h-index
49Co-inventors
75Inventor score
Filing activity: Oct 3, 1986 → Mar 18, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5652141A | Device and process for isolating nucleic acids from cell suspension | Chemistry; Metallurgy | 153 | Expired |
| US5871908A | Process for the determination of in vitro amplified nucleic acids | Chemistry; Metallurgy | 130 | Expired |
| US5057426A | Method for separating long-chain nucleic acids | Physics | 113 | Expired |
| US5795747A | Process for manufacturing new biopolymers | Chemistry; Metallurgy | 64 | Expired |
| US6020186A | Device and process for isolating nucleic acids from cell suspensions | Chemistry; Metallurgy | 56 | Expired |
| US6582903B1 | Method and a device for the evaluation of biopolymer fitness | Emerging Cross-Sectional Technologies | 49 | Expired |
| US7202953B1 | Scanning microscopic method having high axial resolution | Physics | 21 | Expired |
| US6849461B2 | Method and device for the selective withdrawal of components from complex mixtures | Emerging Cross-Sectional Technologies | 17 | Expired |
| US5795720A | Process and device for the separation and detection of components of a mixture of materials by temperature gradient gel electrophoresis | Physics | 15 | Expired |
| US6213735A | Micromechanical ejection pump for separating small fluid volumes from a flowing sample fluid | Physics | 13 | Expired |
| US4912044A | Preparation of mesophilic microorganisms which contain a D-hydantoinase which is active at elevated temperature | Emerging Cross-Sectional Technologies | 8 | Expired |
| US7534576B2 | Method and a device for the evaluation of biopolymer fitness | Emerging Cross-Sectional Technologies | 5 | Active |
| US7241569B2 | Method and a device for the evaluation of biopolymer fitness | Emerging Cross-Sectional Technologies | 3 | Expired |
| US9370531B2 | Method of providing patient specific immune response in amyloidoses and protein aggregation disorders | Emerging Cross-Sectional Technologies | 3 | Active |
| US10874725B2 | Method of providing patient specific immune response in amyloidoses and protein aggregation disorders | Emerging Cross-Sectional Technologies | 3 | Active |
| US5637455A | HIV-2 virus variants | Emerging Cross-Sectional Technologies | 3 | Expired |
| US5849545A | Substrate material for simultaneously binding genotypic and phenotypic substances | Chemistry; Metallurgy | 2 | Expired |
| US5677147A | HIV-2 virus variants | Emerging Cross-Sectional Technologies | 2 | Expired |
| US6156529A | Method for specifically marking a protein | Emerging Cross-Sectional Technologies | 1 | Expired |
| US11179417B2 | Method for obtaining globally activated monocytes | Chemistry; Metallurgy | 1 | Active |
| US6423516B1 | Process and agent for instabilizing viral quasi-species-distributions avoiding resistance phenomena | Emerging Cross-Sectional Technologies | 1 | Expired |
| US11975120B2 | Antimicrobial and/or epithelial cell growth stimulating substance and composition and tissue dressing material | Human Necessities | 0 | Active |
| US7015017B2 | Process and agent for instabilizing viral quasi-species-distributions avoiding resistance phenomena | Emerging Cross-Sectional Technologies | 0 | Expired |
| US9439998B2 | Compositions and methods for disinfecting materials | Emerging Cross-Sectional Technologies | 0 | Active |
| US11311644B2 | Antimicrobial and/or epithelial cell growth stimulating substance and composition and tissue dressing material | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.